The global smart syringes market size was evaluated at USD 7,890.62 million in 2020 and is estimated to reach USD 14,185.45 million by 2027, registering a CAGR of 8.7% during the forecast period. Smart syringes are medical devices engineered with safety mechanisms to prevent the reuse of syringes and regulate unsafe injection practices. They are designed with features such as an in-built inactivation mechanism to protect a person from needle stick injuries and blood-borne diseases such as hepatitis B and C and human immunodeficiency virus (HIV). They cater to a wide range of applications that include vaccination, drug delivery, and blood collection. Different types of smart syringes, including auto-disable (AD) syringes, passive safety syringes, and active safety syringes, are used depending on the nature of the application. Active safety syringes are the most commonly used type of syringes across all healthcare sectors, whereas auto-disable (AD) syringes are the most popular syringes used for vaccination.
Request For Report Description: [ Ссылка ]
